Tuberculosis
0
FDA approves ILUMYA for adults with active psoriatic arthritis
0

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...

0
O-38 – HUMAN MYCOBACTERIUM BOVIS TUBERCULOSIS IN NORTHERN IRELAND: A TEN-YEAR RETROSPECTIVE REVIEW OF EPIDEMIOLOGY, EXPOSURES AND OUTCOMES
0

AbstractBackgroundSince 2019, an apparent increase in human Mycobacterium bovis tuberculosis (TB) notifications has been observed in Northern Ireland (NI), ...

0
O-46 – TUBERCULOSIS INCIDENTS IN HEALTH AND SOCIAL CARE SETTINGS IN THE SOUTH EAST OF ENGLAND 2018 – 2024
0

AbstractBackgroundPulmonary Tuberculosis (TB) in health and social care workers (HSCWs) leads to risk of transmission to vulnerable patients. Guidelines ...

0
P-65 – UNDERSTANDING THE BURDEN OF MYCOBACTERIUM TUBERCULOSIS IMMUNOREACTIVITY IN URBAN AND RURAL POPULATIONS: A SYSTEMATIC REVIEW, META-ANALYSIS, AND EPIDEMIOLOGICAL ANALYSIS
0

AbstractBackgroundTuberculosis (TB) is the leading cause of death from a single infectious pathogen, responsible for one million deaths annually, ...

0
When “Consumption” Wasn’t Tuberculosis: Could Some Cases Have Been Celiac Disease?
0

@TiredPerson, If I understand your post correctly, your GI symptoms started in the last year or two. Did you have any event in the last few years ...

0
Tuberculosis outbreak declared in inner-city Edmonton: Primary Care Alberta
0

Listen to this articleEstimated 2 minutesThe audio version of this article is generated by text-to-speech, a technology based on artificial ...

Daily Deals
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart